296 related articles for article (PubMed ID: 19206007)
1. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
[TBL] [Abstract][Full Text] [Related]
2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
3. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
4. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
5. [Bone mineral density in children before and after completion of cancer treatment].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Kaczmarski M; Piotrowska-Jastrzebska J
Pol Merkur Lekarski; 2004 Jul; 17(97):37-42. PubMed ID: 15559608
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in long-term survivors of childhood cancer.
Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
[TBL] [Abstract][Full Text] [Related]
7. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
[TBL] [Abstract][Full Text] [Related]
8. Skeletal morbidity in childhood acute lymphoblastic leukemia.
Mandel K; Atkinson S; Barr RD; Pencharz P
J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
[TBL] [Abstract][Full Text] [Related]
9. Body composition and bone mass in survivors of childhood cancer.
Muszynska-Roslan K; Konstantynowicz J; Krawczuk-Rybak M; Protas P
Pediatr Blood Cancer; 2007 Feb; 48(2):200-4. PubMed ID: 16602116
[TBL] [Abstract][Full Text] [Related]
10. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone mineral density at different phases of therapy of childhood all.
Maniadaki I; Stiakaki E; Germanakis I; Kalmanti M
Pediatr Hematol Oncol; 2006; 23(1):11-8. PubMed ID: 16326407
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in long-term survivors of childhood cancer.
Arikoski P; Voutilainen R; Kröger H
J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():343-53. PubMed ID: 12729414
[TBL] [Abstract][Full Text] [Related]
14. Bone mass and body composition after cessation of therapy for childhood cancer.
Nysom K; Mølgaard C; Holm K; Hertz H; Michaelsen KF
Int J Cancer Suppl; 1998; 11():40-3. PubMed ID: 9876476
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral status after treatment of malignant lymphoma in childhood and adolescence.
Sala A; Talsma D; Webber C; Posgate S; Atkinson S; Barr R
Eur J Cancer Care (Engl); 2007 Jul; 16(4):373-9. PubMed ID: 17587363
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density decrements and children diagnosed with cancer.
Pagano-Therrien J; Santacroce SJ
J Pediatr Oncol Nurs; 2005; 22(6):328-38. PubMed ID: 16216895
[TBL] [Abstract][Full Text] [Related]
17. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
19. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
20. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
